» Articles » PMID: 16723391

Regulation of Hypermutation by Activation-induced Cytidine Deaminase Phosphorylation

Overview
Specialty Science
Date 2006 May 26
PMID 16723391
Citations 78
Authors
Affiliations
Soon will be listed here.
Abstract

Activation-induced cytidine deaminase (AID) initiates Ig class switch recombination and somatic hypermutation by producing U:G mismatches in DNA. These mismatches also have the potential to induce DNA damage including double-stranded breaks and chromosome translocations; therefore, strict regulation of AID is important for maintaining genomic stability. In addition to transcriptional regulation, it has been proposed that phosphorylation can also modulate AID activity. Using a combination of MS and immunochemical approaches we found that 5-15% of the AID expressed in activated B cells was phosphorylated at serine-38 (p38AID). This form of AID was enriched in the chromatin fraction in activated B cells, suggesting a role for phosphorylation in targeting AID to DNA. Consistent with this idea, serine-38 to alanine mutant AID (AID(S38A)) showed diminished somatic hypermutation activity on artificial and physiological DNA targets. We conclude that a small fraction of AID is phosphorylated in activated B cells and that the modified form contributes disproportionately to hypermutation.

Citing Articles

Mechanism and regulation of secondary immunoglobulin diversification.

Bello A, Hirth G, Voigt S, Tepper S, Jungnickel B Cell Cycle. 2023; 22(18):2070-2087.

PMID: 37909747 PMC: 10761156. DOI: 10.1080/15384101.2023.2275397.


ATR kinase supports normal proliferation in the early S phase by preventing replication resource exhaustion.

Menolfi D, Lee B, Zhang H, Jiang W, Bowen N, Wang Y Nat Commun. 2023; 14(1):3618.

PMID: 37336885 PMC: 10279696. DOI: 10.1038/s41467-023-39332-5.


Activation induced cytidine deaminase: An old friend with new faces.

Cakan E, Gunaydin G Front Immunol. 2022; 13:965312.

PMID: 36405752 PMC: 9670734. DOI: 10.3389/fimmu.2022.965312.


AID in Chronic Lymphocytic Leukemia: Induction and Action During Disease Progression.

Oppezzo P, Navarrete M, Chiorazzi N Front Oncol. 2021; 11:634383.

PMID: 34041018 PMC: 8141630. DOI: 10.3389/fonc.2021.634383.


AID in Antibody Diversification: There and Back Again.

Feng Y, Seija N, Di Noia J, Martin A Trends Immunol. 2020; 41(7):586-600.

PMID: 32434680 PMC: 7183997. DOI: 10.1016/j.it.2020.04.009.


References
1.
Taylor S, Kim C, Vigil D, Haste N, Yang J, Wu J . Dynamics of signaling by PKA. Biochim Biophys Acta. 2005; 1754(1-2):25-37. DOI: 10.1016/j.bbapap.2005.08.024. View

2.
Petersen S, Casellas R, Reina-San-Martin B, Chen H, Difilippantonio M, Wilson P . AID is required to initiate Nbs1/gamma-H2AX focus formation and mutations at sites of class switching. Nature. 2001; 414(6864):660-665. PMC: 4729367. DOI: 10.1038/414660a. View

3.
Wong W, Scott J . AKAP signalling complexes: focal points in space and time. Nat Rev Mol Cell Biol. 2004; 5(12):959-70. DOI: 10.1038/nrm1527. View

4.
Rajewsky K . Clonal selection and learning in the antibody system. Nature. 1996; 381(6585):751-8. DOI: 10.1038/381751a0. View

5.
Rada C, Jarvis J, Milstein C . AID-GFP chimeric protein increases hypermutation of Ig genes with no evidence of nuclear localization. Proc Natl Acad Sci U S A. 2002; 99(10):7003-8. PMC: 124518. DOI: 10.1073/pnas.092160999. View